期刊文献+

重组人生长激素治疗的不良反应 被引量:1

The adverse reactions of recombinant human growth hormone in treatment
原文传递
导出
摘要 生长激素(GH)是人体必需的激素之一。对于生长激素缺乏症(GHD)的儿童,重组人生长激素(rhGH)替代治疗疗效明确,但其仍可引起水钠潴留、良性颅高压、股骨头滑脱、脊柱侧弯、甲状腺功能减退症、糖脂代谢紊乱、继发肿瘤发生的危险性升高等不良反应。对上述不良反应的发生情况、发生机制及其相关的治疗措施等方面进行详细的阐述,有助于指导今后安全用药。 Growth hormone (GH) is one of the essential hormones needed by human body. For chil- dren with growth hormone deficiency ( GHD), the effect of replacement therapy using recombinant human growth hormone (rhGH) is obvious, but still some adverse reactions can be caused, such as sodium and water retention, benign intracranial hypertension, slipped capital femoral epiphysis, scoliosis, hypothyroidism, glu- cose and lipid metabolism disorder, increasing risk of secondary neoplasm, etc. Clarifing the occurrences, mechanisms and related treatments of adverse reactions mentioned above is helpful to guide the safe applica- tion of medication in the future.
作者 王翯 李志红
出处 《国际内分泌代谢杂志》 北大核心 2013年第3期180-182,共3页 International Journal of Endocrinology and Metabolism
关键词 重组人生长激素 不良反应 体液平衡 良性颅高压 骨骼 甲状腺 糖脂代谢 恶性 肿瘤 Recombinant human growth hormone Adverse reaction Body fluid balance Benign in- tracranial hypertension Skeleton Thyroid gland Glucose and lipid metabolism Malignant tumor
  • 相关文献

参考文献16

  • 1Clayton PE, Cowell CT. Safety issues in children and ado-lescents during growth hormone therapy-a review. Growth Horm IGF Res, 2000,10:306-317.
  • 2Cinciripini GS, Donahue S, Borchert MS. Idiopathic intracranial hypertension in prepubertal pediatric patients: characteristics, treatment and outcome. Am J Ophthalmol, 1999,127 : 178-182.
  • 3Saenger P. Metabolic consequences of growth hormone treatment in paediatric practice. Horm Res,2000,53:60-69.
  • 4Growth Hormone Research Society. Consensus guidelines for the diagnosis and treatment of growth hormone ( GH ) deficiency in childhood and adolescence: summary statement of the GH Re- search Society. GH Research Sociery. J Clin Endocrinol Metab, 2000, 85 : 3990-3993.
  • 5Bell J, Parker KL, Swinford RD, et al. Long-term safety of recom- binanthuman growth hormone in children. J Clin Endocrinol Metab,2010,95 : 167-177.
  • 6赵雪妮,吴丹红,崔秀云,宋华.219例应用重组人生长激素的矮小儿童随访调查[J].中国优生与遗传杂志,2007,15(8):109-110. 被引量:2
  • 7Giavoll C, Porretti S, Ferrante E, et al. Recombinant hGH replace- ment therapy and the hypothalamus-pituitary-thyroid axis in chil- dren with GH deficiency : when should we be concerned about the occurrence of central hypothyroidism. J Clin Endocrinol, 2003, 59 : 806-810.
  • 8Seminara S,Stagi S, Candura L, et al. Changes of thyroid function during long-term hGH therapy in GHD ebildren:a possible rela- tionship with catch-up growth. Horm Metab Res, 2005, 37: 751-756.
  • 9Gotherstrom G, Bengtsson BA, Snnnerhagen KS, et al. Tbe effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients. Clin Endocrinol,2005, 62:105-113.
  • 10hoh E, Iida K, del Rincon JP, et al. Diurnal variation in growth hormone receptor messenger ribonucleic acid in liver and skeletal muscle of lit/+ and lit/lit mice. Endocr J,2004, 51:529-535.

二级参考文献6

共引文献2

同被引文献13

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部